Top

Published in:

01-04-2003 | Announcement

Six SPORE PIs have joined Breast Cancer Research's Editorial Board

Author: Bruce AJ Ponder

Published in: Breast Cancer Research | Issue 2/2003

Excerpt

We are delighted to announce that six principal investigators (PI) from the Breast Cancer SPORE programs (Specialized Programs of Research Excellence; http://spores.nci.nih.gov/breast/breast.html) have joined Breast Cancer Research's Editorial Board. …

Title: Six SPORE PIs have joined Breast Cancer Research's Editorial Board
Author: Bruce AJ Ponder
Publication date: 01-04-2003
Publisher: BioMed Central
Published in: Breast Cancer Research / Issue 2/2003
Electronic ISSN: 1465-542X
DOI: https://doi.org/10.1186/bcr586

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2003

Breast cancer cell lines: friend or foe?

Id-1 is not expressed in the luminal epithelial cells of mammary glands

25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10–14 December 2002 Update on clinical research

C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer

Articles selected from Faculty of 1000 in October 2002

Host microenvironment in breast cancer development Inflammatory and immune cells in tumour angiogenesis and arteriogenesis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer